• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Modelling the epidemiology of Escherichia coli ST131 and the impact of interventions on the community and healthcare centres.大肠杆菌ST131的流行病学建模以及干预措施对社区和医疗中心的影响。
Epidemiol Infect. 2016 Jul;144(9):1974-82. doi: 10.1017/S0950268816000030. Epub 2016 Feb 3.
2
Comparison of the microbiological characteristics and virulence factors of ST131 and non-ST131 clones among extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia.引起菌血症的产超广谱β-内酰胺酶大肠埃希菌中ST131和非ST131克隆株的微生物学特征及毒力因子比较
Diagn Microbiol Infect Dis. 2016 Feb;84(2):102-4. doi: 10.1016/j.diagmicrobio.2015.10.015. Epub 2015 Oct 28.
3
Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131.产超广谱β-内酰胺酶大肠埃希菌菌株在母婴定植中的特征:大肠埃希菌 ST131 的流行率。
J Clin Microbiol. 2013 Jun;51(6):1727-32. doi: 10.1128/JCM.03255-12. Epub 2013 Mar 20.
4
Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.产 ESBL 阴性大肠埃希菌 O25b:H4 血清型 131 导致的菌血症:对危险因素、临床特征和结局的深入了解。
Int J Antimicrob Agents. 2017 Apr;49(4):498-502. doi: 10.1016/j.ijantimicag.2016.12.013. Epub 2017 Feb 28.
5
Prolonged colonisation with Escherichia coli O25:ST131 versus other extended-spectrum beta-lactamase-producing E. coli in a long-term care facility with high endemic level of rectal colonisation, the Netherlands, 2013 to 2014.2013年至2014年在荷兰一家直肠定植流行率高的长期护理机构中,大肠杆菌O25:ST131与其他产超广谱β-内酰胺酶大肠杆菌的长期定植情况
Euro Surveill. 2016 Oct 20;21(42). doi: 10.2807/1560-7917.ES.2016.21.42.30376.
6
Trends of extended-spectrum β-lactamase-producing Escherichia coli sequence type 131 and its H30 subclone in a French hospital over a 15-year period.15 年间法国一家医院中产Extended-spectrum β-lactamase 的大肠杆菌 131 型及其 H30 亚克隆的流行趋势
Int J Antimicrob Agents. 2016 Dec;48(6):744-747. doi: 10.1016/j.ijantimicag.2016.09.023. Epub 2016 Nov 4.
7
Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.芝加哥地区产超广谱β-内酰胺酶大肠埃希菌的分子特征:社区医院中 CTX-M-15 型大肠埃希菌流行率较高。
Int J Antimicrob Agents. 2010 Jul;36(1):19-23. doi: 10.1016/j.ijantimicag.2010.02.016. Epub 2010 Mar 31.
8
Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.大肠杆菌序列型 131(ST131)子克隆 H30 作为一种新出现的美国退伍军人中多重耐药病原体。
Clin Infect Dis. 2013 Nov;57(9):1256-65. doi: 10.1093/cid/cit503. Epub 2013 Aug 6.
9
The revolving door between hospital and community: extended-spectrum beta-lactamase-producing Escherichia coli in Dublin.医院与社区之间的旋转门:都柏林产超广谱β-内酰胺酶的大肠杆菌。
J Hosp Infect. 2012 Jul;81(3):192-8. doi: 10.1016/j.jhin.2012.04.021. Epub 2012 Jun 2.
10
Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand.序列类型 131 fimH30 和 fimH41 亚克隆在澳大利亚和新西兰的大肠杆菌分离株中。
Int J Antimicrob Agents. 2015 Apr;45(4):351-8. doi: 10.1016/j.ijantimicag.2014.11.015. Epub 2015 Jan 13.

引用本文的文献

1
The neglected model validation of antimicrobial resistance transmission models - a systematic review.抗菌药物耐药性传播模型中被忽视的模型验证——一项系统综述
Antimicrob Resist Infect Control. 2025 May 28;14(1):59. doi: 10.1186/s13756-025-01574-x.
2
High rate of multi-drug resistant Escherichia coli isolated from patients with urinary tract infections in Ifakara-Tanzania: implications for empirical antibiotic treatment guidelines and stewardship programs.在坦桑尼亚伊法卡拉地区,从尿路感染患者中分离出的多重耐药大肠杆菌比例很高:对经验性抗生素治疗指南及管理计划的影响
Antimicrob Resist Infect Control. 2025 May 2;14(1):41. doi: 10.1186/s13756-025-01557-y.
3
The contribution of community transmission to the burden of hospital-associated pathogens: A systematic scoping review of epidemiological models.社区传播对医院相关病原体负担的影响:流行病学模型的系统综述。
One Health. 2024 Dec 16;20:100951. doi: 10.1016/j.onehlt.2024.100951. eCollection 2025 Jun.
4
Transmission of gram-negative antibiotic-resistant bacteria following differing exposure to antibiotic-resistance reservoirs in a rural community: a modelling study for bloodstream infections.农村社区中不同抗生素耐药库暴露后革兰氏阴性抗生素耐药菌的传播:血流感染的建模研究。
Sci Rep. 2022 Aug 5;12(1):13488. doi: 10.1038/s41598-022-17598-x.
5
Examining the role of person-to-person transmission during a verocytotoxigenic Escherichia coli outbreak in Ontario, Canada.考察加拿大安大略省肠出血性大肠杆菌暴发期间人际传播的作用。
BMC Res Notes. 2022 May 21;15(1):187. doi: 10.1186/s13104-022-06075-3.
6
Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Update on Molecular Epidemiology and Treatment Options.产超广谱β-内酰胺酶肠杆菌科细菌:分子流行病学和治疗选择的最新进展。
Drugs. 2019 Sep;79(14):1529-1541. doi: 10.1007/s40265-019-01180-3.
7
Population-level mathematical modeling of antimicrobial resistance: a systematic review.人群水平抗菌药物耐药性的数学建模:系统评价。
BMC Med. 2019 Apr 24;17(1):81. doi: 10.1186/s12916-019-1314-9.
8
Intestinal colonization due to ST131: risk factors and prevalence.ST131 导致的肠道定植:危险因素和流行率。
Antimicrob Resist Infect Control. 2018 Nov 15;7:135. doi: 10.1186/s13756-018-0427-9. eCollection 2018.
9
Application of dynamic modelling techniques to the problem of antibacterial use and resistance: a scoping review.应用动态建模技术解决抗菌药物使用和耐药问题:范围综述。
Epidemiol Infect. 2018 Dec;146(16):2014-2027. doi: 10.1017/S0950268818002091. Epub 2018 Jul 31.
10
Benefits and unintended consequences of antimicrobial de-escalation: Implications for stewardship programs.抗菌药物降阶梯治疗的益处与意外后果:对管理计划的启示
PLoS One. 2017 Feb 9;12(2):e0171218. doi: 10.1371/journal.pone.0171218. eCollection 2017.

本文引用的文献

1
Escherichia coli ST131, an intriguing clonal group.大肠杆菌ST131,一个引人关注的克隆群。
Clin Microbiol Rev. 2014 Jul;27(3):543-74. doi: 10.1128/CMR.00125-13.
2
A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131.一个新的克隆群体彻底席卷:大肠杆菌序列类型131的神秘出现。
Antimicrob Agents Chemother. 2014 Sep;58(9):4997-5004. doi: 10.1128/AAC.02824-14. Epub 2014 May 27.
3
The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.产超广谱β-内酰胺酶大肠杆菌 ST131 流行是由一个单一的高致病性亚克隆 H30-Rx 驱动的。
mBio. 2013 Dec 17;4(6):e00377-13. doi: 10.1128/mBio.00377-13.
4
Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications.属于全球新兴流行克隆群O25b/ST131的大肠杆菌:危险因素及临床意义
J Antimicrob Chemother. 2014 Mar;69(3):809-14. doi: 10.1093/jac/dkt405. Epub 2013 Oct 11.
5
Within-lineage variability of ST131 Escherichia coli isolates from humans and companion animals in the south of Europe.欧洲南部人类和伴侣动物中ST131大肠杆菌分离株的谱系内变异性。
J Antimicrob Chemother. 2014 Jan;69(1):271-3. doi: 10.1093/jac/dkt343. Epub 2013 Sep 10.
6
Modelling the transmission of healthcare associated infections: a systematic review.建模医疗保健相关感染的传播:系统评价。
BMC Infect Dis. 2013 Jun 28;13:294. doi: 10.1186/1471-2334-13-294.
7
A basic dynamic transmission model of Staphylococcus aureus in the US population.美国人群中金黄色葡萄球菌的基本动力学传播模型。
Epidemiol Infect. 2014 Mar;142(3):468-78. doi: 10.1017/S0950268813001106. Epub 2013 May 23.
8
Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts.大肠杆菌序列型 131 是一种主要的、具有抗药性的克隆群,与医疗保健和老年宿主有关。
Infect Control Hosp Epidemiol. 2013 Apr;34(4):361-9. doi: 10.1086/669865. Epub 2013 Feb 13.
9
Extended-spectrum β-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors.零售鸡肉和人类中产超广谱β-内酰胺酶的大肠杆菌:菌株、质粒、耐药基因和毒力因子的比较。
Clin Infect Dis. 2013 Feb;56(4):478-87. doi: 10.1093/cid/cis929. Epub 2012 Dec 14.
10
Escherichia coli O25b:H4/ST131 are prevalent in Spain and are often not associated with ESBL or quinolone resistance.大肠杆菌 O25b:H4/ST131 在西班牙很常见,通常与 ESBL 或喹诺酮类药物耐药无关。
Enferm Infecc Microbiol Clin. 2013 Jun-Jul;31(6):385-8. doi: 10.1016/j.eimc.2012.09.005. Epub 2012 Nov 20.

大肠杆菌ST131的流行病学建模以及干预措施对社区和医疗中心的影响。

Modelling the epidemiology of Escherichia coli ST131 and the impact of interventions on the community and healthcare centres.

作者信息

Talaminos A, López-Cerero L, Calvillo J, Pascual A, Roa L M, Rodríguez-Baño J

机构信息

Grupo de Ingeniería Biomédica,Universidad de Sevilla,Seville,Spain.

Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva,Hospitales Universitarios Virgen Macarena y Virgen del Rocío,Seville,Spain.

出版信息

Epidemiol Infect. 2016 Jul;144(9):1974-82. doi: 10.1017/S0950268816000030. Epub 2016 Feb 3.

DOI:10.1017/S0950268816000030
PMID:26838136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9150611/
Abstract

ST131 Escherichia coli is an emergent clonal group that has achieved successful worldwide spread through a combination of virulence and antimicrobial resistance. Our aim was to develop a mathematical model, based on current knowledge of the epidemiology of ESBL-producing and non-ESBL-producing ST131 E. coli, to provide a framework enabling a better understanding of its spread within the community, in hospitals and long-term care facilities, and the potential impact of specific interventions on the rates of infection. A model belonging to the SEIS (Susceptible-Exposed-Infected-Susceptible) class of compartmental models, with specific modifications, was developed. Quantification of the model is based on the law of mass preservation, which helps determine the relationships between flows of individuals and different compartments. Quantification is deterministic or probabilistic depending on subpopulation size. The assumptions for the model are based on several developed epidemiological studies. Based on the assumptions of the model, an intervention capable of sustaining a 25% reduction in person-to-person transmission shows a significant reduction in the rate of infections caused by ST131; the impact is higher for non-ESBL-producing ST131 isolates than for ESBL producers. On the other hand, an isolated intervention reducing exposure to antimicrobial agents has much more limited impact on the rate of ST131 infection. Our results suggest that interventions achieving a continuous reduction in the transmission of ST131 in households, nursing homes and hospitals offer the best chance of reducing the burden of the infections caused by these isolates.

摘要

ST131大肠杆菌是一个新兴的克隆群体,它通过毒力和抗菌耐药性的结合在全球范围内成功传播。我们的目标是基于目前对产超广谱β-内酰胺酶(ESBL)和不产ESBL的ST131大肠杆菌流行病学的了解,开发一个数学模型,以提供一个框架,便于更好地理解其在社区、医院和长期护理机构中的传播,以及特定干预措施对感染率的潜在影响。我们开发了一个属于SEIS(易感-暴露-感染-易感)类别的 compartmental模型,并进行了特定修改。该模型的量化基于质量守恒定律,这有助于确定个体流动与不同 compartment之间的关系。根据亚群体规模,量化可以是确定性的或概率性的。该模型的假设基于多项已开展的流行病学研究。基于该模型的假设,一项能够使人际传播持续减少25%的干预措施显示,ST131引起的感染率显著降低;对于不产ESBL的ST131分离株,其影响比对产ESBL的分离株更大。另一方面,一项单纯减少抗菌药物暴露的干预措施对ST131感染率的影响要有限得多。我们的结果表明,在家庭、养老院和医院中持续减少ST131传播的干预措施,提供了减轻这些分离株所致感染负担的最佳机会。